Quoris3D, one of the UK and Ireland’s leading dental laboratories and guided surgery specialists, has entered into a significant investment and partnership agreement with ROE Dental Laboratory, one of the United States’ most respected and innovative full-service dental labs. The transformative deal not only solidifies a relationship that has been steadily building since 2020, but positions Quoris3D as a central hub for delivering cutting-edge dental solutions across Europe.

For the dental industry, this announcement marks more than just financial alignment. It represents the formalisation of a shared vision between two technologically driven, patient-focused organisations. And for Quoris3D, it is a clear signal that its leadership in the UK and Irish markets, and the company’s deep commitment to clinical education and digital innovation, has earned the confidence and backing of one of the biggest names in North American dentistry.

A Shared Vision Built on Innovation

The relationship between Quoris3D and ROE Dental Laboratory was originally forged around the revolutionary GuidedSMILE system—ROE’s fully patented, stackable, full-arch guided surgery solution that has become the industry’s gold standard, and the world’s number one system of its kind. As the exclusive European license holder of the system, Quoris3D has spent the past four years establishing the GuidedSMILE solution in the UK and Irish markets, while simultaneously driving forward its own innovations in clinically driven treatment planning, original product solutions, and clinical education.

Now, this new partnership deepens the connection, bringing ROE’s financial and strategic influence to bear on Quoris3D’s future direction. For ROE, it’s a calculated move to further their reach into the European market, made possible by aligning with a lab whose technological infrastructure, educational platforms, and clinical relationships and expertise already reach across the continent.

BJ Kowalski, CEO of ROE Dental Laboratory, emphasised the strategic rationale behind the investment, commenting: “Our financial investment in Quoris3D will allow both organisations to leverage each other’s strengths to bring unique solutions to the European dental market. We are not simply investing in a company—we are investing in a shared future of innovation, quality, and clinical success. Quoris3D’s clinical expertise and agility in innovating, combined with their established presence and relationships in the European market, makes them the ideal partner as we expand our global vision.”

Growth, infrastructure and education

For Quoris3D, the investment comes at a pivotal time. The company is preparing for a major expansion of its state-of-the-art facility, with a clear intent to scale both production capacity and educational outreach. The alignment with ROE will provide the resources and strategic support to accelerate that growth—bringing new technologies and solutions to market faster, and expanding the accessibility of advanced full arch services to a broader network of clinicians across Europe.

“This marks a major milestone for us as a business, and for our people and customers”, said Dr. James Hamill, CEO of Quoris3D. “To have such an established and respected partner at our side will bring not only significant advantages to Quoris3D, but more importantly, these advantages will filter through to our customers.

“We share a vision for clinically driven innovation, and with the strength and reputation of the ROE team, we now have a stronger foundation than ever to deliver on that vision for dental professionals across Europe. A collaboration with one of the industry’s true giants gives us a springboard to accelerate our growth; it opens up a vast reservoir of experience and market insight which will enable us to develop our propositions much more quickly and effectively.

“That’s ultimately going to benefit every one of our customers and their patients, whilst allowing us to continually innovate in a way which will cement our position as a market leader this side of the Atlantic.”

James Hamill has led Quoris3D’s rise with a focus on creating solutions that bridge the gap between technology and the lab, and chairside reality. His background as a practicing implantologist has shaped Quoris3D’s offering, which is unique in its combination of clinical insight, engineering precision, and educational excellence.

As guided surgery specialists, the company’s approach to the provision of support pathways to its clinicians encompasses educational courses, digital resources, and a newly announced clinician mentoring programme. This educational and mentoring support is complemented by a level of case planning which offers the perfect blend of predictability and flexibility, achievable only with what are reputed to be the most skilled and clinically astute planners in the industry.

Such combinations of support ‘beyond the guide’ are viewed as key assets in the new partnership, and with ROE’s backing, such programmes are expected to expand, bringing a new generation of clinicians into the fold and ensuring that the sophisticated solutions the lab offers are delivered with a full understanding of their clinical potential.

Leveraging GuidedSMILE across Europe

At the core of this collaboration is the mutual belief in the transformative power of the GuidedSMILE system. Developed and patented by ROE Dental, and now EU-registered and deployed across Europe via Quoris3D, the system offers a fully stackable, guided surgical solution for full arch cases—one that is both predictable and repeatable, addressing many of the longstanding challenges of traditional full arch and immediate load implant workflows.

While many labs offer digital design or printed components, very few offer the level of clinical support, accuracy, and system integration that GuidedSMILE delivers. This is where Quoris3D and ROE differentiate themselves: both companies bring not just products, but holistic workflows and support services that have been tested and refined over thousands of cases.

“GuidedSMILE isn’t just a surgical guide—it’s a comprehensive treatment protocol,” Hamill explained. “We’ve seen firsthand how the system can enhance surgical confidence and dramatically improve outcomes. With this new partnership, we’re now in a position to make those benefits available to more clinicians, in more countries, with more robust support than ever before.”

A turning point for European digital dentistry

The deal signals more than just bilateral growth—it speaks to the evolving nature of dentistry itself. As the European dental sector continues to embrace digital transformation, labs like Quoris3D are becoming critical partners in the provision of care. No longer passive suppliers, today’s leading labs offer fully integrated treatment planning, manufacturing, and surgical support services that shape clinical workflows from diagnosis to final prosthesis.

For ROE, this investment isn’t just a foothold in Europe—it’s a strategic commitment to a vision of dentistry where digital systems enhance predictability, patient satisfaction, and practice profitability. And for Quoris3D, it’s an affirmation of their pioneering work, and a springboard for the next phase of expansion.

Industry insiders already see the move as a watershed moment. With one of America’s most advanced labs investing heavily in European infrastructure, it’s clear that the region’s dental sector is gaining increased recognition for its growth potential and innovative spirit. And with Quoris3D at the centre of that momentum, the lab is now well-positioned to lead Europe’s next chapter in dental innovation.

Looking ahead

As both companies look to the future, the tone is one of collaboration, not consolidation. Each lab brings unique capabilities to the table, and the partnership is structured to preserve that individuality while expanding shared impact. From product development and clinical support to education and logistics, the Quoris3D–ROE alliance is designed to enhance what each company already does well—now at greater scale, with global insight.

Perhaps most importantly, this partnership reflects a renewed commitment to the clinicians at the frontlines of care. By enhancing workflows, improving product access, and delivering on the promise of digital precision, both companies are positioning themselves as true partners to the practices they serve.

“We’re building something that goes far beyond a financial agreement,” Kowalski concluded. “This is about setting a new standard for how labs operate—locally, regionally, and internationally. Together, ROE and Quoris3D will not only shape the future of dentistry, we will support the clinicians driving that future, every step of the way.”

Tags: GuidedSmile, Quoris3D, ROE Dental Laboratory